Implementation plan for measures of drug production 2020

On:
In: License, Medicine/medical devices, NMPA
The measures for the supervision and administration of drug production will be officially implemented on July 1, 2020, and the National medical product administration published the implementation plan on April 3. Since July 1, 2020, the new measures shall be implemented for the production license of preparations, APIs and Chinese herbal pieces., the drug production license applications before July 1, which have been accepted but not approved shall be handled in accordance with the new management measures after July 1.The existing “drug production license” shall continue to be valid within the validity period. Change, reissue and reissue after July 1,Read More →

Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is ＄5,500 Best! Paolo yue Email: yuefeng7832@hotmail.com Cell: 008613501397114

Existing Users Log In
   
New User Registration
*Required field

Related posts:

  1. Administrative measures for food production license 2019
  2. Management requirements for drug record and data-Trial
  3. Implementation of GMP for veterinary drug production 2020
  4. Quality management Code for veterinary drug production 2020
  5. Measures for the administration of drug registration 2020
  6. Implementation of Drug Administration Law
  7. Interim Measures of Subsidy Funds for Food and Drug Administration
  8. Implementation of the Pharmacopoeia of China 2020
  9. Implementation of the measures for imported medicinal materials
  10. 2020 industrial standardization plan for medical device